EDAP TMS S.A.
EDAP TMS S.A. develops, manufactures, and markets non-surgical medical devices that treat urological diseases. EDAP's line of lithotripters utilize shockwaves to pulverize kidney stones. The company's Ablatherm system incorporates a technology called High Intensity Focused Ultrasound (HIFU), in which ultrasound waves are used to destroy prostate cancer cells. The company is also developing HIFU for the treatment of other types of tumors. Key subsidiaries EDAP Technomed, Inc. and EDAP Technomed Co. Ltd. market the company's products to the US and Japan, respectively. EDAP TMS was established in 1979.
Contact Details
Executives
Chairman
Philippe Chauveau
CEO
Marc Oczachowski